Positive Review

Jan 16, 2019

A Canadian expert panel report recommends public coverage of the gene therapy Kymriah if its cost goes down, the Globe and Mail reports.

Kymriah, a CAR-T therapy from Novartis, has been approved by Health Canada to treat acute lymphoblastic leukemia in children and diffuse large B-cell lymphoma in adults, it notes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

WHO Panel Announced

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

Research Reproducibility Scores

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

Tests for All Diagnosed

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

This Week in Science

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.

Main menu

Positive Review

To read the full story....

The Scan

WHO Panel Announced

Research Reproducibility Scores

Tests for All Diagnosed

This Week in Science

What's Popular?

Bio-Rad Clinical ddPCR Test, Diagnostic System Get FDA Clearance

Hologic Aptima HIV-1 Assay Receives Dual Claim CE Marking

Bioneer HIV-1 Dx Kit Gets Korea FDA Approval

GenomeDx Biosciences to Pay $2M to Settle Allegations of Improper Medicare Billing

Q&A: OIR Director Timothy Stenzel Discusses Precision Medicine Efforts During First Year at FDA

Sponsorships